Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update announcing an EARLY_PHASE1 study to evaluate tolerability, safety and efficacy of VGN-R13 in patients with Amyotrophic Lateral Sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• VGN-R13

Snippet

Sponsor: Hong Chen | Conditions: Amyotrophic Lateral Sclerosis (ALS) | EARLY_Phase 1 | Status: RECRUITING